[O1-1] SARS2-2

[O1-1-11] Development of an innovative research platform using human iPSC-derived cells for respiratory viruses including SARS-CoV-2

*Kouji Sakai¹, Shotaro Maehana², Ryota Mikawa³, Koji Tamai³, Misato Nishikawa⁴, Yurika Moteki², Yutaro Fukuzumi², Yasushi Ami¹, Kazuaki Takehara⁵, Hidero Kitasato², Knut Woltjen⁴, Yoshinori Yoshida⁴, Gotoh Gotoh³ (1. National Institute of Infectious Diseases, 2. Graduate School of Medical Sciences, Kitasato University, 3. Graduate School of Medicine, Kyoto University, 4. Center for iPS Cell Research and Application (CiRA), Kyoto University, 5. Tokyo University of Agriculture and Technology)